Search

Effects of dietary Original XPC (XPC) on 17 selected blood variables in commercial layer pullets challenged with the virulent, low-passage R strain of Mycoplasma gallisepticum (R low MG) were investigated. Hy-Line W-36 pullets sourced from M. gallisepticum-clean layer breeders were fed a basal diet with XPC (1.25 kg/metric ton) or without from hatch until 12 wk of age (woa). At 8 and 10 woa, half of the birds in each dietary treatment were challenged with R low MG. Blood samples were taken immediately before the initial R low MG challenge at 8 woa and again at 12 woa (4 wk after challenge). At 8 woa, blood pH was lower and glucose concentration was higher in the preassigned challenge treatment groups. At 12 woa, the concentration of oxygen dissolved in the blood was significantly lower in the R low MG-challenged group than the unchallenged group of birds regardless of dietary treatment. The R low MG challenge significantly increased blood carbon dioxide partial pressure, calcium, sodium, anion gap, osmolality, glucose, and corticosterone levels but significantly decreased blood oxygen partial pressure, oxyhemoglobin concentration, concentration of oxygen dissolved in the blood, chloride, and pH levels. Because blood pH and glucose concentration at 8 woa were examined before challenge, their baseline values were biased with respect to challenge treatment before treatment was applied. However, the lack of a significant main effect due to diet at 8 woa for blood pH and glucose concentration, along with the other 15 blood variables, indicate that the baseline data with respect to dietary treatment were unbiased, allowing for real dietary effects to be accurately assessed. In conclusion, layer pullets challenged with R low MG undergo a stress response associated with changes in various physiological blood variables, and a decrease in pH and increase in carbon dioxide partial pressure, in association with a lack of change in bicarbonate, indicates that the stress response caused by the R low MG challenge was associated with respiratory acidosis. Nevertheless, feeding XPC did not influence the effects of challenge treatment on these postchallenge physiological blood values., (Copyright © 2020. Published by Elsevier Inc.)

Mycoplasma gallisepticum (MG) is a bacterial pathogen that causes production losses in layer chickens. To combat MG, multiage layer facilities vaccinate pullets by either spray or eye-drop vaccination. The objective in this study was to evaluate the use of in ovo vaccination as a potential alternative for MG vaccination. Layer embryos at 18 d of incubation were either not-injected (control), or were hand-injected with either commercial Marek's disease vaccine diluent alone or with a high, medium, low, or very low dosage of a live attenuated strain F (FMG) vaccine suspended in the commercial diluent. Hatch success and residual egg embryonic mortality were determined after 23 d of incubation. Six hatched chicks per treatment were swabbed for the detection of FMG at 4 different sites (trachea, mouth and esophagus, yolk sac membrane, and the lumen of the duodenal loop) via real-time PCR. Embryos were found to be administered 106 CFU per dose in the high treatment, 104 CFU/dose in the medium treatment, 102 CFU/dose in the low treatment, and between 5.06 and 5.93 CFU/dose in the very low treatment. Hatch of embryonated eggs was decreased by the medium and high doses (P = 0.02). These embryos died while pipping. No FMG was detected in the control and diluent-injected chicks. In the FMG treatments, FMG was found in all sites and dosages, with a greater number of positive chicks found in the higher FMG dosage treatments. These findings indicate the potential practicality of vaccinating layer embryos with FMG by in ovo injection based on the observed hatch success at lower dosages. Also, once injected into the amnion, the bacteria are present in the upper respiratory and gastrointestinal tracts as well the yolk sac membrane and the small intestine of hatchlings. Future research will need to ascertain the effects of FMG administered by in ovo injection on posthatch immunity and mortality., (© 2017 Poultry Science Association Inc.)

Mycoplasma gallisepticum (MG) is a major and economically significant pathogen of avian species. When administered before lay, F-strain MG (FMG) can reduce egg production during lay, but the ts-11 strain of MG (ts11MG) does not exert this effect. Two trials were conducted to determine the effects of pre-lay vaccinations of ts11MG, MG-Bacterin (MGBac), or their combination, in conjunction with an FMG vaccination overlay after peak production on the digestive and reproductive organ characteristics of Hy-Line W-36 layers housed in biological isolation units (4 units per treatment, 10 birds per unit). The following vaccination treatments were administered at 10 wk of age (woa): 1) Control (no vaccinations); 2) MGBac; 3) ts11MG; and 4) ts11MG and MGBac combination (ts11MG+MGBac). At 45 woa, half of the birds were vaccinated with a laboratory stock of high passage FMG. In both trials, parameters determined in 4 birds per unit at 55 woa included: BW; fatty liver hemorrhagic syndrome incidence; mean number of mature ovarian follicles; ovarian, oviduct, and small intestine weights; and the weights and lengths of the various portions of the oviduct and small intestine. Treatment effects were observed for the weights of the entire small intestine and the duodenum, jejunum, and ileum, as percentages of BW; and for vagina weight as a percentage of total oviduct weight. In general, the weights of the small intestine and its 3 components were increased in response to the FMG vaccine that was administered at 45 woa. An FMG vaccination at 45 woa may increase relative intestine weight in layers; however, use of a prelay MGBac vaccine alone or in combination with ts11MG, with or without an FMG overlay, does not affect the gross characteristics of their digestive and reproductive organs, and may be used without having an adverse effect on their performance, as was observed in a previous companion study., (© 2015 Poultry Science Association Inc.)

Increases in circulating acute phase protein (APP) levels occur in reaction to systemic infections in animals. However, no previous research has been conducted to monitor possible changes in APP levels of birds in response to prelay vaccinations of various live attenuated Mycoplasma gallisepticum vaccines in conjunction with their subsequent use as an overlay vaccine during the production period. Serum concentrations of the APP, α1-acid glycoprotein (AGP), were determined on d 0, 1, 3, 7, 14, and 28 after subjecting commercial laying hens to one of the following treatments at 10 wk of age (woa): 1) control (no vaccination); 2) ts-11 strain M. gallisepticum (ts11MG) vaccination; 3) M. gallisepticum-bacterin (MGBac) vaccination; and 4) ts11MG and MGBac combination (ts11MG & MGBac) vaccination. Furthermore, at 45 woa, the birds in half of the units assigned to each treatment group were vaccinated with high-passage F-strain M. gallisepticum (HpFMG). Birds in treatment 1 that were (single control) and were not (double control) vaccinated with HpFMG, and birds in treatments 2, 3, and 4 that were vaccinated with HpFMG were further tested during lay on d 0, 1, 3, 7, 14, and 28 after vaccination. On d 7, 14, and 28 postvaccination at 10 woa, the ts11MG & MGBac, ts11MG, and MGBac group AGP concentrations were not different from one another, but all were higher than those in the control group. Similarly, on d 3, 7, and 14 postvaccination, the single control, and the MGBac ts11MG, and ts11MG & MGBac treatment groups that were later vaccinated with HpFMG at 45 woa, were not different, but all were higher than that in the double control group. In conclusion, elevated circulation AGP concentrations may be used to detect and confirm subclinical infections in pullets up to 28 d after having been vaccinated with ts11MG, MGBac, or their combination. Furthermore, in association with depressed performance, elevated serum AGP concentrations in layers may be used to confirm HpFMG infections up to 28 d after its use as a vaccine., (Poultry Science Association Inc.)

Effects of 2 supplemental concentrations of dietary poultry fat (PF) and the combination of PF, phytase (PHY), and 25-hydroxycholecalciferol [25(OH)D] on the gross digestive and reproductive organ characteristics of commercial layers inoculated with F-strain Mycoplasma gallisepticum (FMG) were investigated in 2 trials. Sham and FMG inoculations were administered at 12 wk (before lay) or 22 wk (onset of lay), dietary treatments [basal control diet (BCD); BCD with 0.75% supplemental PF (LPFD); BCD with 1.50% supplemental PF (HPFD); HPFD additionally supplemented with 0.013% PHY and 0.025% 25(OH)D] were initiated at 20 wk of age, and organ characteristics were determined at 58 wk of age. In proportion to small intestine weight, jejuna were heavier in birds inoculated at 22 wk rather than at 12 wk of age. In hens inoculated at 22 wk of age, percentage of infundibulum weight was increased by FMG. The proportional length of infundibula in birds fed HPFD with PHY and 25(OH)D was longer than in those fed LPFD. In birds inoculated with FMG at 22 wk of age, BW was greater in those fed HPFD with or without added PHY and 25(OH)D in comparison with those fed LPFD, whereas LPFD increased percentage of oviduct and magnum weights when compared with the HPFD and BCD groups, respectively. Percentage of duodenum weight in birds that were fed HPFD with PHY and 25(OH)D was greater compared with those fed LPFD in the wk 22 sham and wk 12 FMG inoculation groups, but was also greater than in those fed BCD in the wk 12 FMG inoculation group. Conversely, percentage of duodenum weight was greater in birds fed LPFD compared with those fed HPFD after a wk 22 FMG inoculation. However, despite the effects of the supplemental combination of 1.50% PF, PHY, and 25(OH)D on the oviduct and small intestine structures, it did not result in a subsequent influence on layer performance, as indicated in a previous companion report.

The effects of 2 levels of supplemental dietary poultry fat (PF) and the combination of PF, phytase (PHY), and 25-hydroxycholecalciferol (D(3)) on the performance of commercial layers inoculated with F-strain Mycoplasma gallisepticum (FMG) were investigated in 2 trials. Sham and FMG inoculations were administered at 12 (before lay) and 22 (early in lay) wk and dietary treatments [basal control diet (BCD), BCD with 0.75% supplemental PF, BCD with 1.50% supplemental PF, and BCD with 1.50% supplemental PF, 0.013% PHY, and 0.025% D(3)] were initiated at 20 wk of age. Hen BW, egg weight, and egg production (EP) were determined every 4 wk between 24 and 58 wk of age. Feed consumption (FC) and feed conversion were determined in 4-wk intervals beginning on wk 25 and ending on wk 58, and total mortality and mean EP were determined over the entire 24 to 58-wk period. The addition of 0.75 and 1.50% PF increased BW at wk 48 and 58, respectively, and supplemental PF at the 1.50% level increased the BW of hens that had been inoculated (sham or FMG) on wk 22 and reduced the FC of hens inoculated on wk 12. Feed conversion was decreased in the 25 to 28- and 57 to 58-wk age periods and increased in the 45 to 48-wk age periods by an FMG inoculation. In birds inoculated at 22 wk of age, FMG increased egg weight. Although EP was reduced at wk 24 and was increased at wk 58 by FMG, total EP was not affected. In conclusion, an inoculation of FMG at either 12 or 22 wk of age can result in a relative shift in EP from the early to late stage of lay without affecting total EP, and although the BW and FC responses of hens to added dietary PF were influenced by their age and the age of inoculation, use of the supplemental combination of PHY and D(3) had no additional effect on performance when provided in conjunction with 1.50% PF.

Effects of F-strain Mycoplasma gallisepticum (FMG) inoculation and 1.5% supplemental dietary poultry fat (PF) on the digestive and reproductive organ characteristics of commercial layers at 58 wk of age were investigated. Sham and FMG inoculations were administered at 12 (before lay) and 22 (early in lay) wk of age, and dietary treatments (basal control diets and basal control diets with PF) were initiated at 20 wk of age. Supplemental PF increased BW and decreased isthmal length relative to total oviduct length in hens. Various oviduct segments were also affected by the type and age of inoculation, and these effects were further influenced by the use of PF. In comparison to their time-specific sham-inoculated controls, infundibulum weight relative to BW was increased when birds were inoculated with FMG at 22 wk, whereas isthmus weight relative to total oviduct weight was increased by FMG inoculation at 12 wk of age. However, PF affected infundibulum length relative to total oviduct length only in sham-inoculated birds, and PF increased magnum weight relative to total oviduct weight only in birds inoculated at 22 wk of age (sham or FMG). Furthermore, PF decreased isthmus weight relative to total oviduct weight only in birds that were sham-inoculated (12 or 22 wk). In conclusion, the inoculation of FMG at 12 or 22 wk may increase the relative contributions of the isthmus and infundibulum, respectively, to the total mass of the oviduct. In addition, PF may decrease the relative length of the isthmus and increase the relative weight of the magnum in the oviducts of birds that have been inoculated at 22 wk of age (sham or FMG). Previous studies have shown 1.5% supplemental dietary PF to influence feed consumption throughout lay and performance early in lay in hens that were inoculated with FMG at 12 wk of age. However, the current results suggest that these influences are associated with gross changes in the oviduct but not the digestive tract of layers.

Effects of F-strain Mycoplasma gallisepticum (FMG) inoculation and 1.5% supplemental dietary poultry fat (PF) on the egg yolk characteristics of commercial layers at 24, 34, 44, 50, and 58 wk of age were investigated. Sham and FMG inoculations were administered at 12 and 22 wk of age and dietary treatments (basal control and basal control with 1.5% supplemental PF) were initiated at 20 wk of age. Yolk lipid concentration was reduced on wk 24 in birds that had been inoculated at 12 or 22 wk of age with FMG. The use of 1.5% supplemental PF increased percentage of yolk weight and yolk:albumen ratio across age and inoculation treatment. At 58 wk of age, concentrations of yolk palmitic acid increased and those of oleic and linolenic acid decreased when sham inoculations were given at 22 rather than at 12 wk of age. However, FMG inoculations given at 22 rather than at 12 wk increased palmitoleic acid and decreased stearic acid yolk concentrations. At 12 wk of age, FMG inoculations decreased yolk palmitoleic, oleic, and linolenic acid concentrations while causing increased yolk stearic and arachidonic acid levels when compared with sham inoculations. Furthermore, 1.5% supplemental PF decreased concentrations of palmitic and oleic acid and increased those of linoleic acid in the yolk at 58 wk of age. Despite the interaction of 1.5% supplemental PF with the prelay inoculation of FMG on early (18 to 26 wk) layer performance noted in a previous report, the effects of a prelay FMG inoculation and 1.5% supplemental PF on the egg yolk characteristics examined in the current study were independent of each other. This suggests that 1.5% supplemental PF is not effective in modulating the effects of an FMG inoculation at 12 wk of age on hen egg yolk characteristics between 24 and 58 wk of age and that the combined effects of PF supplementation and FMG inoculation on performance do not influence egg yolk characteristics.

The effects of F-strain Mycoplasma gallisepticum (FMG) inoculation and 1.5% supplemental dietary poultry fat (PF) on the performance of commercial layers between 20 and 58 wk of age were investigated. Sham and FMG inoculations were administered at 12 (before lay) and 22 (early in lay) wk and dietary treatments (basal control diets and basal control diets with 1.5% supplemental PF) were initiated at 20 wk of age. Mortality at wk 47 and 53 was greatest in birds inoculated with FMG at 22 wk. Feed consumption from 20 to 23 and from 52 to 55 wk of age was greater in birds that were inoculated with FMG (12 or 22 wk). However, feed consumption decreased in birds that were inoculated at 12 wk (sham or FMG) when 1.5% supplemental PF was added to the diet. Percentage of total egg production (EP) between 22 and 58 wk of age was highest in hens that were inoculated with FMG at 22 wk. Furthermore, weekly EP increased at wk 27 and 58 and decreased at wk 47 after birds had been inoculated with FMG (12 or 22 wk), and increased at 22 wk and decreased at 54 wk when inoculations (sham or FMG) were given at 22 wk. Egg weight was increased at wk 29, 31, 39, 40, 42, 44, 53, and 58 in birds that were inoculated with FMG (12 or 22 wk); however, there were no coherent treatment effects on eggshell quality. An FMG inoculation at 22 wk may promote total EP through 58 wk, whereas the inoculation of commercial layers with FMG (12 or 22 wk) may increase subsequent feed consumption during the early and late stages of EP and increase egg weight throughout lay. However, the supplementation of hen diets with 1.5% PF beginning at 20 wk of age may reduce subsequent feed consumption throughout lay in birds having experienced a prelay (12 wk) inoculation.

Two trials were conducted to determine the effects of a prelay ts-11-strain Mycoplasma gallisepticum (ts-11MG) vaccination alone or in combination with subsequent time-specific F-strain M. gallisepticum (FMG) inoculations on the blood characteristics of commercial laying hens. The following 4 treatments were utilized: 1) sham vaccination at 10 wk of age, 2) vaccination of ts-11MG at 10 wk, 3) ts-11MG at 10 wk overlaid by FMG inoculation at 22 wk, and 4) ts-11MG at 10 wk overlaid by FMG at 45 wk. Parameters measured in both trials were whole blood hematocrit, plasma protein, serum cholesterol, serum triglycerides, and serum calcium. No significant age x treatment interactions and no significant age or treatment main effects were observed for any of the blood parameters investigated, except for serum calcium. At wk 22, serum calcium concentrations were increased by vaccination with ts-11MG at 10 wk, and levels were further increased when the ts-11MG vaccination at 10 wk was overlaid by an FMG inoculation at 22 wk. These results suggest that ts-11MG vaccination at 10 wk of age alone or combined with F-strain inoculum overlays at either 22 or 45 wk may be used without any consequential effects on hematocrit or the lipid and protein levels in the blood of commercial layers. Because elevations in serum calcium were not associated with changes in hen performance, as reported in a previous companion article, it is further suggested that prelay ts-11MG vaccination before FMG inoculation overlays during lay may provide adequate protection against field strain M. gallisepticum infections while being innocuous to layer performance.

Two trials were conducted to determine the effects of a prelay 6/85-strain Mycoplasma gallisepticum (6/85MG) vaccination alone or in conjunction with time-specific F-strain M. gallisepticum (FMG) inoculation overlays on the gross reproductive and digestive organ characteristics of commercial egg-laying hens. In each trial, the following 4 treatments were applied: 1) sham vaccination at 10 wk of age; 2) vaccination of 6/85MG at 10 wk; 3) 6/85MG at 10 wk overlaid by FMG inoculation at 22 wk; and 4) 6/85MG at 10 wk overlaid by FMG at 45 wk. Two birds per isolation pen (experimental replicate unit) were necropsied at the end of both trials to observe the effects of treatment on liver weight, liver lipid and moisture concentrations, incidence of fatty liver hemorrhagic syndrome, ovary weight, mature ovarian follicle numbers, and the total and segmental weights, lengths, and histologies of the oviduct and small intestine. The applied treatments affected only liver moisture. Liver moisture content was greater in birds vaccinated with 6/85MG at 10 wk alone or in conjunction with FMG at 45 wk in comparison with sham vaccinated controls and birds that received a 6/85MG vaccination at 10 wk overlaid by an FMG inoculation at 22 wk. Prelay 6/85MG vaccinations may be a suitable substitute for prelay FMG inoculations, and FMG overlays during lay on prelay 6/85MG vaccinations may also provide continual protection against field-strain MG infections without eliciting any subsequent suppressive effects on performance, as noted in an earlier study.

The effects of 6/85-strain Mycoplasma gallisepticum (6/85MG) inoculation alone or in conjunction with F-strain M. gallisepticum (FMG) overlays and their timing on the blood characteristics of commercial egg-laying hens were investigated. Control birds received sham inoculations at 10 wk of age. Birds in a second treatment group were inoculated with 6/85MG at 10 wk of age, those in a third treatment group were inoculated with 6/85MG at 10 wk followed by an overlay inoculation of FMG at 22 wk, and those in a fourth treatment group were inoculated with 6/85MG at 10 wk followed by an overlay inoculation of FMG at 45 wk. Parameters investigated at 24, 32, 43, and 47 wk were hematocrit, plasma total protein, and serum calcium, triglycerides, and cholesterol. No significant treatment effects were noted for hematocrit, serum triglycerides, or serum cholesterol. However, at wk 32, plasma protein was greater in birds that received 6/85MG at 10 wk or 6/85MG at 10 wk and FMG at 22 wk in comparison to controls. Also, at wk 47, serum calcium concentration was greater in birds that received 6/85MG at 10 wk and FMG at 45 wk compared with controls and those that received 6/85MG at 10 wk and FMG at 22 wk. These results suggest that the prelay inoculation of pullets with 6/85MG may subsequently elevate plasma protein, and in conjunction with an FMG overlay at 45 wk, may increase serum calcium concentrations in laying hens.

Mycoplasma infections are pandemic in multiage layer chicken flocks, with Mycoplasma gallisepticum being the species of greatest concern to commercial egg producers. Live M. gallisepticum vaccines are presently being used to help control M. gallisepticum outbreaks. However, vaccination of layers with F-strain M. gallisepticum may adversely affect egg production. In the present study, 2 trials were conducted to compare the effects of 2 currently available live Mycoplasma vaccines (the ts11- and F-strains), used in conjunction, on internal egg and eggshell characteristics. The following 4 inoculation treatments were used: 1) sham at 10 wk of age (control), 2) ts11 at 10 wk, 3) ts11 at 10 wk overlaid by F at 22 wk, and 4) ts11 at 10 wk overlaid by F at 45 wk. In each trial at various ages between 23 and 57 wk of age, percentage of yolk weight, percentage of yolk moisture, percentage of yolk lipid, percentage of albumen weight, Haugh unit scores, and percentage of shell weight of eggs were assessed. At wk 32, percentage of yolk lipid was increased in eggs belonging to the ts11 at 10 wk and ts11 at 10 wk overlaid by F at 22 wk treatment groups in comparison with controls. There was also a significant decrease in percentage of albumen weight in eggs in the treatment with ts11 at 10 wk overlaid by F at 22 wk, as well as a decrease in Haugh unit scores in the ts11 at 10 wk treatment in comparison with controls during post-peak lay. Percentage of yolk moisture, percentage of egg yolk weight, and percentage of eggshell weight in layers were not significantly affected by a 10-wk ts11 inoculation alone or in conjunction with subsequent overlay inoculations of F during lay. It is suggested that a 10-wk inoculation of commercial layers with ts11-strain M. gallisepticum may reduce the negative impacts of a prelay F-strain M. gallisepticum inoculation on performance while providing protection against subsequent field strain M. gallisepticum infections.

The effects of a prelay 6/85-strain Mycoplasma gallisepticum (6/85 MG) inoculation alone or in conjunction with subsequent F-strain M. gallisepticum (FMG) inoculations during lay on the internal egg characteristics of commercial egg-laying hens were investigated. In the first 2 treatment groups, birds were sham inoculated or were inoculated with 6/85 MG at 10 wk of age. In a third treatment group, birds were inoculated with 6/85 MG at 10 wk in conjunction with a subsequent inoculation of FMG at 22 wk, and in a fourth treatment group, birds were inoculated with 6/85 MG at 10 wk in conjunction with a subsequent inoculation of FMG at 45 wk. Percentage yolk weight, albumen weight, yolk moisture, and yolk lipid were determined at 24, 32, 43, 47, and 58 wk of hen age. The data from wk 24, 32, and 43 were analyzed separately from those at wk 47 and 58. Furthermore, yolk fatty acid profiles were determined at wk 58. The applied treatments affected yolk moisture and fatty acid profiles. Across wk 24, 32, and 43, yolk moisture content was higher in birds inoculated with 6/85 MG at 10 wk and FMG at 22 wk when compared with control birds and those inoculated with 6/85 MG at 10 wk alone. In addition, at wk 58, yolk palmitic, oleic, and linolenic acid concentrations were affected differently by treatment. A 22-wk FMG inoculation in birds previously inoculated with 6/85 MG at 10 wk may increase yolk moisture content, and alterations in yolk palmitic, oleic, and linolenic acid levels with treatment may be manifested by disturbances in fatty acid synthesis.

Mycoplasma bacteria are virtually ubiquitous in layer chicken flocks, and Mycoplasma gallisepticum is the species of greatest concern to commercial egg producers. Live M. gallisepticum vaccines were initially approved by the USDA for use in commercial layers in 1988 to help control M. gallisepticum outbreaks. In the present study, 2 trials were conducted to determine the effects of 2 currently available live Mycoplasma vaccines (the ts11-and F-strains) when used together. The following 4 inoculation treatments were used: 1) sham inoculation at 10 wk of age, 2) ts11 at 10 wk, 3) ts11 at 10 wk overlaid by the F-strain at 22 wk, and 4) ts11 at 10 wk overlaid by the F-strain at 45 wk. In each trial, at various ages between 18 and 57 wk of age, hen mortality; BW; egg weight; egg production; eggshell breaking strength; incidences of egg blood spots, egg meat spots, and eggshell pimpling; and eggshell weight per unit of surface area were assessed. The effects of inoculation treatment on egg weight at 27, 37, and 38 wk were inconsistent and variable. Eggshell pimpling and egg blood spot incidences at 56 wk were highest in eggs belonging to the ts11 at 10 wk/F-strain at 45 wk group. Despite increases in pimpling and blood spot incidences very late in production because of the ts11 at 10 wk/F-strain at 45 wk treatment, performance in layers was not adversely affected by a 10-wk ts11 inoculation alone or in conjunction with subsequent overlay inoculations of the F-strain during lay. It is therefore suggested that the 10-wk inoculation of commercial layers with ts11 may reduce the negative impacts of a prelay F-strain inoculation on performance, as reported in earlier studies, while providing protection against subsequent field strain M. gallisepticum infections. Furthermore, the ts11- and F-strain M. gallisepticum treatment combinations may overcome some of the inadequacies that prelay ts11- or F-strain M. gallisepticum vaccines may have when given independently.

The effects of dietary supplementation with phytase and 25-hydroxycholecalciferol on the performance characteristics of commercial layers that were inoculated prelay (12 wk of age) or at the onset of lay (22 wk of age) with F-strain Mycoplasma gallisepticum were assessed. Experimental layer diets, which included a basal control diet or the same diet supplemented with 0.025% phytase and 25-hydroxycholecalciferol, were fed from 20 through 58 wk of age. Weekly and total egg production were determined from 22 through 58 wk, and egg weight and various internal egg and eggshell quality characteristics were examined at 34, 50, and 58 wk of age. F-strain M. gallisepticum inoculation decreased egg production at the beginning of lay (wk 22 and 23) but increased post-peak lay at wk 45. However, there were no treatment effects of any kind on total egg production, egg weight, or any of the internal egg and eggshell characteristics examined during lay. In conclusion, dietary supplementation with phytase and 25-hydroxycholecalciferol did not affect layer performance or interact with the effects of F-strain M. gallisepticum inoculation; however, F-strain M. gallisepticum inoculation resulted in a shift in egg production from wk 22 to 45 without having an overall effect on total egg production.

The effects of 6/85-strain Mycoplasma gallisepticum (6/85MG) inoculation alone or in conjunction with a F-strain M. gallisepticum (FMG) overlay and its timing on the performance of commercial egg-laying hens were investigated. Control birds received sham inoculations at 10 wk of age. A second treated group of birds was inoculated with 6/85MG at 10 wk of age, a third treatment group of birds was inoculated with 6/85MG at 10 wk and received an overlay of FMG at 22 wk, and a fourth treatment group was inoculated with 6/85MG at 10 wk followed by a 45-wk overlay inoculation of FMG. Parameters investigated between 20 and 55 wk of age included BW, mortality, weekly and total egg production, egg weight, relative eggshell conductance, eggshell weight per unit of surface area, percentage shell weight, yolk/albumen ratio, and egg shape index. Hen age effects were reported for BW, egg weight, yolk/albumen ratio, and egg production. No treatment effects or hen age x treatment interactions were noted for those parameters except for yolk/albumen ratio, and no significant effects of any kind were noted for the remaining parameters examined. At wk 47, a significant treatment effect for yolk/albumen ratio was noted. The yolk/albumen ratio in the group of birds that received 6/85MG at 10 wk followed by an overlay of FMG at 22 wk was significantly lower than the sham control birds and those that were inoculated with 6/85MG at 10 wk followed by a 45-wk overlay inoculation of FMG. Prelay 6/85MG inoculations may be a suitable substitute for prelay FMG inoculations, and FMG overlays during lay on prelay 6/85MG inoculations may provide continual protection without eliciting any subsequent suppressive effects on performance.

In 2 consecutive trials of the current study, the effect of the age of application of S6-strain Mycoplasma gallisepticum (S6MG) inoculation on the blood characteristics of commercial layers housed and maintained under controlled conditions was determined. The ages of inoculation compared were those before lay at 10 wk of age, during onset of lay at 22 wk of age, and during postpeak lay at 45 wk of age. In each trial, hematocrit, plasma protein, and serum cholesterol, triglycerides, and Ca were determined at 20, 24, 32, 43, 47, and 58 wk of age. The data from both trials were pooled then analyzed together, whereas, data from wk 20 (effect of 10-wk S6MG inoculation); data from wk 24, 32, and 43 (effects of 10- and 22-wk S6MG inoculations); and data from wk 47 and 58 (effects of 10-, 22-, and 45-wk S6MG inoculations) were analyzed separately. At wk 20, hematocrit was higher in birds inoculated with S6MG at 10 wk compared with sham-inoculated birds, and across wk 24, 32, and 43, serum Ca was higher in birds inoculated with S6MG at 10 or 22 wk compared with those that were sham-inoculated. Serum Ca level across wk 47 and 58 was higher in birds inoculated with S6MG at 10 wk compared with sham-inoculated controls and birds inoculated with S6MG at 22 wk, with 45-wk S6MG-inoculated birds being intermediate. The response of serum cholesterol level at 47 wk to S6MG inoculation at either 10, 22, or 45 wk compared with controls was nearly opposite to that of the response observed at 58 wk. However, serum triglycerides were depressed only at wk 47 due to the 45-wk S6MG inoculation compared with all other treatments. Variable post-peak alterations in serum Ca and lipids occur in response to the timing of S6MG inoculation in layers housed under controlled conditions.

Commercial laying hens maintained under controlled conditions were experimentally inoculated with the S6 strain of Mycoplasma gallisepticum (S6MG) at 45 wk of age. This resulted in depressed liver lipid concentration, and inoculations at 20 and 45 wk affected the size of various portions of the reproductive tract. In 2 consecutive trials of the current study, the effect of age of application of S6MG inoculation on the egg yolk characteristics of commercial layers similarly housed and maintained under controlled conditions was determined. The ages of inoculation compared were prior to lay at 10 wk of age, during onset of lay at 22 wk of age, and during postpeak lay at 45 wk of age. In each trial, yolk moisture and total lipid content were determined at 24, 32, 43, 47, and 58 wk of age. Yolk cholesterol concentration and yolk fatty acid profiles at wk 47 and 58 were also examined. Data from wk 24, 32, and 43 (effects of S6MG inoculations at 10 and 22 wk) and data from wk 47 and 58 (effects of S6MG inoculations at 10, 22, and 45 wk) were analyzed separately. The data of both trials were pooled then analyzed together. Across wk 47 and 58, percentage yolk lipid was significantly lower in eggs laid by birds inoculated at 10 wk compared with those inoculated at 45 wk. Sham-inoculated control and 22-wk inoculated groups had intermediate percentage yolk lipids. Compared with sham-control and 10-wk S6MG inoculation groups across wk 47 and 58, yolk myristic, oleic, and linolenic acid concentrations were reduced, whereas yolk stearic and arachidonic acid levels were increased by either 22- or 45-wk S6MG inoculations. In comparison with all other treatment groups at wk 47, yolk linoleic acid concentration was reduced by S6MG inoculation at 45 wk. Variable postpeak alterations in yolk total lipid and fatty acid content occur in response to the timing of S6MG inoculation in layers housed under controlled conditions.

Experimental inoculation of commercial laying hens with the S6-strain of Mycoplasma gallisepticum (S6MG) at 20 wk of age, while being maintained under ideal conditions, has previously been shown to affect the lengths and weights of various portions of the reproductive tract. Two trials were conducted in the current study to compare the effects of S6MG inoculation prior to lay at 10 wk of age, during onset of lay at 22 wk of age, and during lay at 45 wk of age on the digestive and reproductive organs of commercial layers similarly housed and maintained under ideal conditions. In each trial, liver weight, liver moisture and lipid concentration, incidence of fatty liver hemorrhagic syndrome, ovary weight, ovarian mature follicle numbers, weights and lengths of the oviduct and oviductal regions, and weights and lengths of the small intestine and small intestinal regions were examined at 60 wk of hen age. At 60 wk, liver lipid concentration was depressed, and isthmus weight, as a percentage of total oviduct weight, was increased in birds that had been inoculated with S6MG at 45 wk. Alterations in liver lipid content and weight of the isthmal portion of the oviduct may occur in response to S6MG inoculation during the later stages of production in layers housed under ideal conditions.

Experimental inoculation with the F-strain of Mycoplasma gallisepticum (FMG) at 12 wk of age has been shown to affect the performance, liver, reproductive organs, and yolk lipid characteristics of commercial layers. Therefore, this study was conducted to determine the serum lipoprotein characteristics of commercial egg-laying hens at 16 wk of age and throughout lay after inoculation with FMG at 12 wk of age. Mean diameters of very low density lipoproteins (VLDL) were determined for the 10th, 50th, and 90th percentiles of serum total VLDL of each hen. Percentages of total serum cholesterol recovered in VLDL and low and high density lipoprotein particle classes were also determined. Inoculation of birds with FMG at 12 wk did not change the physical properties or relative concentrations of their circulating lipoproteins. However, the age of the bird had significant differential effects on all the parameters examined. These data demonstrate that FMG-inoculation at 12 wk of age does not affect the lipoproteins of laying hens, but because these birds were housed in biological isolation units, these results do not preclude the possibility that these yolk precursors may be affected in FMG-infected birds that are housed in facilities in which there are increased levels of environmental stress. These data further suggest that alterations in liver, reproductive organs, and yolk lipid characteristics in response to FMG, as noted in previous reports on commercial layers, are not mediated through changes in circulating VLDL diameters.

In two trials, the effects of an F-strain Mycoplasma gallisepticum (FMG) inoculation at 12 wk of age on the blood characteristics of commercial Single Combed White Leghorn laying hens were investigated throughout lay. Variables measured in both trials were whole blood hematocrit, plasma protein (PP), and serum cholesterol, triglycerides (ST), and calcium. In both trials, hematocrit at 20 wk of age was significantly increased in birds inoculated with FMG. In trial 1, ST and PP were significantly increased at 22 wk of age by FMG, while ST and PP were significantly decreased in FMG-inoculated birds at wk 54 and 52, respectively. When combined with the establishment of an FMG infection, the initial weeks of egg production become particularly stressful to the bird. Increases in these independent blood parameters between 8 and 10 wk postchallenge are suggestive of compensatory responses in these birds to an FMG challenge. Postpeak decreases in both ST (54 wk) and PP (52 wk) in FMG-infected birds may be the result of a more chronic effect of FMG on lipid and protein synthesis in the liver. These data are the first to suggest that alterations in egg production in response to FMG-infection in commercial layers, as noted in a previous report, may be associated with changes in hematocrit. However, because ST and PP were not affected by FMG in both trials, the responses of these blood parameters to FMG-infection may be inconsistent among flocks.

F-strain Mycoplasma gallisepticum (FMG) may alter reproductive performance in layers through its effects on lipid metabolism. Therefore, the influences of 1.5% supplemental dietary poultry fat (PF) and FMG infection on the early performance of commercial egg-laying hens were determined. Birds were either sham- or FMG-inoculated at 12 wk, and experimental diets were initiated at 20 wk of age. Body weight at 12, 20, and 24 wk, total daily egg mass, feed consumption and feed conversion at 20 and 24 wk, weekly egg weight between 19 and 26 wk, weekly egg production (EP) between 18 and 26 wk, and weekly mortality between 12 and 26 wk of age were determined. Inoculation with FMG reduced EP at 18 and 19 wk of age. Between 20 and 26 wk, FMG reduced EP in birds fed control diets, conversely, PF eliminated differences in EP between sham- and FMG-inoculated birds. Furthermore, at wk 20 and 24, birds consumed less feed when fed PF-supplemented diets than when fed control diets if they were sham-inoculated, but the difference in feed consumption between diets was ameliorated if birds were previously inoculated with FMG. These data demonstrate that the effects of a 12-wk inoculation of FMG on EP and feed consumption through 26 wk of age in commercial egg-laying chickens can be modified by 1.5% supplemental dietary P F. More specifically, PF may alleviate reductions in early EP due to FMG.

In two trials, the effects of F-strain Mycoplasma gallisepticum (FMG) on the contents of egg yolks from commercial Single Comb White Leghorn laying hens were investigated over a production cycle. Ten hens were assigned to each of 8 (trial 1) or 16 (trial 2) negative pressure fiberglass biological isolation units. Birds in half of the total units served as sham-inoculated controls, and those in the other half were inoculated with FMG at 12 wk of age. Eggs were collected and yolks were harvested at various times during the prepeak, peak, and postpeak periods of both trials for constituent analysis. Yolk constituents analyzed in these trials included moisture, total lipids, cholesterol, triglycerides, phospholipids, and fatty acids. In both trials, total yolk lipid at 22 wk of age was significantly decreased in birds inoculated with FMG. In trial 1, yolk cholesterol at 28 wk was significantly decreased in FMG-inoculated birds. Yolk linoleic acid in trial 1 and yolk stearic and arachidonic acids in trial 2 were significantly increased in FMG-inoculated birds compared to FMG-free birds. In trial 2, yolk myristic, palmitoleic, and oleic acid percentages were significantly decreased in FMG-inoculated birds compared to FMG-free birds. These data suggest that alterations in egg production in commercial layers in response to an FMG infection at 12 wk of age are associated with changes in yolk composition.

Mycoplasma gallisepticum (MG), a reproductive/respiratory pathogen in poultry, has been implicated in suboptimum egg production and decreased hatchability. Commercial layer hens raised in a controlled environment were inoculated with the S6 strain of MG at 20 wk of age. The S6 inoculation had no effect on bird weight, egg production, digestive tract weight and length, or histopathologic lesion scores, although significant differences were noted in the lengths and weights of various portions of the reproductive tract. This study shows that S6MG inoculation does not detrimentally affect layer hen performance when in the absence of environmental stressors customary to a caged layer facility.

Experimental inoculation with the F-strain of Mycoplasma gallisepticum (FMG) between 8 and 18 wk of age is known to affect reproductive performance in commercial layers. Therefore, two trials were conducted to determine if changes in digestive and reproductive organ characteristics also occur in commercial laying hens infected with FMG at 12 wk of age. In Trial 1, liver weight, liver lipid and moisture contents, ovary weight, ovarian follicular hierarchy, and the weights, lengths, and histologies of the infundibulum, magnum, isthmus, uterus, and vagina were determined. In Trial 2, fatty liver hemorrhagic syndrome (FLHS) incidence and the weights, lengths, and histologies of the duodenum, jejunum, and ileum were determined in addition to the parameters examined in Trial 1. In both trials, the average number of mature (diameter > or = 12 mm) ovarian follicles was lower in FMG-inoculated hens in comparison to controls. Also, magnum/oviduct (cm/cm) length was reduced in treated birds. In Trial 2, isthmus/BW and isthmus/oviduct (g/ g) weight were decreased at 46 wk of age, and vagina/ BW and vagina/oviduct (g/g) weight were decreased at both 20 and 36 wk of age due to FMG treatment. In Trial 2, FMG treatment resulted in a 50% increase in the number of FLHS birds. Furthermore, treatment caused a decrease at 20 wk of age and an increase at 44 wk of age in liver moisture content. However, the intestinal characteristics examined were not affected by FMG inoculation. Altered liver, ovarian, and reproductive organ characteristics were associated with FMG infection in commercial layers. More specifically, FMG inoculation at 12 wk resulted in a higher incidence of FLHS, ovarian follicular regression, and decreased isthmal and vaginal proportions of the reproductive tract. These data clearly demonstrate that alterations in performance and egg characteristics of layers inoculated with FMG at 12 wk of age are related to mutual functional disturbances in the liver, ovary, and oviduct without concomitant intestinal changes.

The effects of F-strain Mycoplasma gallisepticum (FMG) inoculation during the pullet period on the subsequent performance and egg characteristics of commercial Single Combed White Leghorn hens were evaluated. In two trials, BW, feed consumption, egg production (EP), egg weight, egg size class, relative eggshell water vapor conductance, and relative percentages of eggshell, yolk and albumen weights were determined through approximately 60 wk of age. In each trial, pullets at 12 wk of age were randomly assigned to negative pressure biological isolation units. Birds in one-half of the total units were inoculated with FMG, and the other half were sham-inoculated with sterile media. In both trials, onset of lay was delayed approximately 1 wk in layers inoculated with FMG. Control birds that had not been previously inoculated with FMG laid their first egg at 18 wk of age, while birds that had been previously inoculated with FMG laid their first egg at 19 wk of age. In Trial 1, FMG-inoculated hens laid significantly fewer total eggs, which became apparent at each week after Week 42. In Trial 2, a numerical decrease in total EP occurred, and the percentage of undersized eggs laid by FMG-inoculated birds was significantly lower at 19 wk of age but was higher at 20 and 21 wk when compared to controls. Mortality was not significantly different between the treatments in either trial. These data demonstrate that when birds are housed in isolation facilities and inoculated with FMG at 12 wk of age, onset of lay is delayed. These data also suggest that FMG may lead to delays in undersize EP and decreases in total EP. However, because significant FMG effects on these parameters were observed in only one trial, additional studies may be necessary to verify these effects.

Mycoplasma gallisepticum (MG) is a reproductive/respiratory disease in poultry implicated in suboptimum egg production and decreased hatchability. Commercial layer hens raised in a controlled environment were inoculated with the S6 strain of MG at 10 wk of age. Egg production and selected egg and egg quality parameters were quantitated over the entire lay cycle for inoculated and control birds. The S6 inoculation had no effect on bird weight, egg production, associated egg quality parameters, or histopathologic lesion scores. This study shows that in the absence of environmental stressors a prelay S6 MG inoculation does not produce detrimental effects on layer hen performance.